The total synthesis of clusianone was accomplished through the stereoselective construction of a bicyclo[3.3.1]nonane derivative via a three-step sequence, which has been utilized for the total syntheses of nemorosone, garsubellin A, and hyperforin: intramolecular cyclopropanation, formation of a geminal dimethyl group, and regioselective ring opening of cyclopropane. Further elaboration, including chemo-and stereoselective hydrogenation to generate the C7 stereogenic center and cross-metathesis to construct prenyl groups in the side-chains, was employed to complete the total synthesis of clusianone.
Clusianone (1) (Figure 1) , isolated from the bark and broken twigs of Clusia congestiflora collected near Fresno, Colombia, as a yellow crystalline material (mp 150-152°C) [1] , has been reported to exhibit antiviral activity against both HIV [2] and Epstein-Barr virus [3] .
Clusianone possesses a trioxygenated bicyclo[3.3.1]nonane skeleton with a benzoyl group at C3, a gem-dimethyl group at C8, and prenyl groups at C6, C7, and C9. The relatively simple structure and fascinating biological activity of clusianone have made it an attractive synthetic target. Consequently, total syntheses of clusianone have been reported by five research groups thus far [4] [5] [6] [7] [8] [9] [10] [11] , and during the synthetic studies by Simpkins and co-workers, the absolute structure of 1 was elucidated [7] . We have been conducting research into the collective total synthesis of polycyclic polyprenylated acylphloroglucinols (PPAPs) [12] [13] [14] [15] [16] [17] , and as a component of it, the total synthesis of clusianone via the approach developed by us is herein reported.
PPAPs feature complex and diverse structures that contain a highly oxygenated and densely substituted bicyclo[3.3.1]nonane ( Figure 1 ) or bicyclo[3.2.1]octane core with prenyl or geranyl side chains, among others [18] . The PPAP family currently includes more than 110 compounds and the number of members is still increasing. Some PPAPs have the same scaffold with different substituents and exhibit diverse biological activities. As mentioned above, clusianone exhibits antiviral activity, but hyperforin shows antidepressant and anti-tumor activities [19] . On the other hand, nemorosone exhibits anti-HIV and anti-tumor activities [20] , and garsubellin A is a potent inducer of choline acetyltransferase [21] .
We envisioned that development of an efficient synthetic strategy for the bicyclo[3.3.1]nonane core structure would facilitate structure-activity relationship studies on PPAPs, and would pave the way to discovering new drug candidates. Some PPAPs, e.g., the four compounds shown in Figure 1 , have the same bicyclo[3.3.1]nonane core with stereogenic centers and oxygen functionalities at the same positions. On the basis of these structural features and the hidden symmetry of the structure, we have developed an approach to bicyclo[3.3.1]nonane derivative 5 which is useful for the synthesis of a wide range of PPAPs. Indeed, we have recently reported the stereoselective total syntheses of nemorosone [15] , garsubellin A [16] , and hyperforin [17] .
As shown in Scheme 1, our approach to bicyclo[3.3.1]nonane derivative 5 consists of three reactions: intramolecular cyclopropanation (IMCP) of α-diazo-β-ketone 2 (Step I) followed by stereoselective alkylation of the cyclopropane 3 ( Step II) and finally, regioselective ring opening of the cyclopropane moiety in compound 4 (Step III). Since the desymmetrization occurs in Step I, the reaction could be made enantioselective by the use of a chiral catalyst.
Step II would enable the introduction of two different substituents at the C8 position by stereoselective alkylation from the less-hindered convex face to generate the all-carbon quaternary stereogenic center that is required for the synthesis of hyperforin 956 Natural Product Communications Vol. 8 (7) 
stereoselective alkylation
Step II regioselective ring opening
Step III Scheme 1: Our approach to bicyclo[3.3.1]nonane derivative 5 by a three-step sequence: intramolecular cyclopropanation, construction of C8 quaternary carbon center, and regioselective ring opening of cyclopropane.
( Figure 1 ).
Step III leads to 5 because the electron-donating methoxy group on cyclopropane and the electron-withdrawing ketone moiety cooperatively induce regioselective ring opening under acidic conditions.
Preparation of compound 7 (Scheme 2), which corresponds to compound 5 (Scheme 1), was carried out in line with total syntheses of nemorosone [15] and garsubellin A [16] , which employed the above approach. Thus, α-diazo-β-ketone 2, which is required for IMCP, was prepared from 2,6-dimethoxybenzoic acid methyl ester 6 in seven steps. IMCP of 2 with a catalytic amount of CuOTf and achiral bisoxazoline ligand afforded cyclopropane 3, which was dimethylated and treated with acid to afford the desired diketone 7 as a single isomer (58% yield over three steps). Ligand A (4 mol %) toluene, rt Scheme 2: Preparation of 7 [15, 16] .
We envisioned that compound 12 (Scheme 3) would be a key intermediate for the total synthesis of clusianone because prenyl groups at the C1 and C7 positions were expected to be constructed by cross-metathesis of allyl groups with isobutene at the same positions. Compound 7 has been converted to 12 in the total synthesis of garsubellin A [16] . These transformations feature the chemo-and stereoselective hydrogenation of 8 with Crabtree's catalyst (0.5 mol %) [22] , which is thought to proceed via the directing effect of the internal C2-C3 methoxyalkene, affording compound 9 as a single isomer. Further transformation of 9 to 12 includes the allylic oxidation at the C4 position of 10 [15] [16] [17] 23] successfully affording ketone 11; this was followed by removal of the C7 acetate, formation of the triflate, and a coupling reaction with divinylcuprate, and regioselective prenylation at the C5 position to afford 12 [5, 7, 16, 24] . Scheme 3: Preparation of 12 [16] .
As the C3 benzoyl group in clusianone is relatively reactive, it was planned to install this at a late stage of the synthesis and the C1 prenyl was constructed first. A straightforward access to the C1 allyl group is to use a coupling reaction. Hence, the coupling reaction of the triflate 13 with divinylcuprate [25] was examined (Scheme 4). Compound 13 was easily prepared from 12 in two steps, but 13 was reactive and decomposed during purification by silica gel chromatography. Accordingly, 13 was used for the coupling reaction without purification. However, no reaction occurred.
Considering that the preparation of 12 by the same method was successful (Scheme 3), the coupling reaction of 13 with divinylcuprate is thought to suffer from the steric hindrance arising from the C1 quaternary stereogenic center.
Consequently, we discarded the coupling reaction method and employed a Wittig reaction to construct the C1 allyl group (Scheme 5). The TIPS group of 12 was removed by TBAF, and subsequent Dess-Martin oxidation afforded aldehyde 15, followed by Wittig reaction with a methoxymethylidene-triphenylphosphorane, acid hydrolysis of the methoxyalkene, and Wittig reaction again to afford compound 14. It should be noted that the Wittig reaction of 15 was sluggish at 0°C and took 14 h to be completed at 30°C, indicating the steric hindrance around the C1 formyl group.
The cross-metathesis of 14 with isobutene in the presence of Grubbs II reagent at 60°C afforded a single product [6, [15] [16] [17] [26] [27] [28] [29] , which was subjected to C3 benzoylation. Deprotonation at the C3 hydrogen required use of LTMP because reduction of the C9 ketone by LDA occurred [15] . Benzoylation of the C3 position proceeded cleanly to give compound 16 in 93% yield (2 steps). Finally, the C2 methyl ether was cleaved under Krapcho's conditions [5, 15-17, 26, 27] to afford the final product, which spectroscopically matched naturally occurring clucianone (1) in all respects (i.e., 1 H and 13 C NMR, IR, and MS), thereby confirming the total synthesis of clucianone (1).
In conclusion, we accomplished the total synthesis of clucianone (1) starting from methyl 2,6-dimethoxybenzoate in a total of 28 steps. Our approach involves a bicyclo[3.3.1]nonane derivative which was prepared by a three-step sequence: intramolecular cyclopropanation, construction of the C8 all-carbon quaternary stereogenic center, and regioselective ring opening of the cyclopropane. Further transformations to obtain clucianone (1) include chemo-and stereoselective hydrogenation to generate the C7 stereogenic center and concomitant cross-metathesis with isobutene to construct trisubstituted alkenes in side-chains. The catalytic asymmetric intramolecular cyclopropanation for PPAPs and its application to the enantioselective total synthesis of PPAPs are now under investigation, and the results will be reported in due course.
Experimental
General: 1 H and 13 C NMR spectra were recorded on either 400 MHz or 500 MHz spectrometers. 1 H and 13 C chemical shifts are reported in ppm downfield from tetramethylsilane (TMS, δ scale) with the solvent resonances as internal standards. The following abbreviations were used to explain the multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; band, several overlapping signals; brs, broad; Cq, quaternary carbon; CH, methine carbon; CH 2 , methylene carbon; CH 3 , methyl carbon. IR spectra were recorded on a FT/IR spectrometer. To confirm the 1 H and 13 C NMR peak assignments (Supporting Information) and carbon multiplicities, 1 H NMR, BCM, DEPT, COSY, HMQC, HMBC, and NOESY methods were used. All reactions were carried out under an argon atmosphere with dry, freshly distilled solvents under anhydrous conditions, unless otherwise noted. All reactions were monitored by TLC carried out on 0.25 mm silica gel plates using UV light as visualizing agent and phosphomolybdic acid and heat as developing agents. Silica gel (60, particle size 0.040-0.063 mm) was used for flash chromatography. Preparative thin-layer chromatography (PTLC) separations were carried out on self-made 0.3 mm silica gel plates. THF and Et 2 O were distilled from sodium/benzophenone ketyl. Toluene was distilled from sodium. MeOH was distilled with a small amount of magnesium and I 2 . Benzene and MeCN were distilled from CaH 2 , and all commercially available reagents were used without further purification. Optical rotations were measured on a polarimeter at a wavelength of 589 nm. High resolution mass spectra (HRMS) were obtained by electrospray ionization (ESI) recorded in a TOF mass spectrometer (Time-of-Flight mass spectrometer), and theoretical monoisotopic molecular masses were typically ≤5 ppm. Melting point was uncorrected. TLC Rfs of purified compounds were included.
(1R*,5R*,7S*)-7-Allyl-1-hydroxymethyl-2-methoxy-8,8dimethyl-5-prenylbicyclo[3.3.1]non-2-ene-4,9-dione (12a):
To a stirred solution of 12 (269.4 mg, 0.536 mmol) in THF (5.4 mL) was added TBAF in THF (2.7 mL, 1.0 M, 2.7 mmol, 5.0 equiv.) at room temperature. Then, the reaction mixture was warmed to 40°C. After the reaction was completed, saturated aqueous NH 4 Cl (20 mL) was added to the reaction mixture, and the aqueous layer was extracted with Et 2 O (20 mL×2). The combined organic layers were washed with brine (40 mL×1), dried (Na 2 SO 4 ), filtered, and concentrated under reduced pressure. The crude 12a was used for the next step without further purification. (1R*,5R*,7S*)-7-Allyl-1-(2-methoxyethene)-2-methoxy-8,8-dimethyl-5-prenylbicyclo[3.3.1]non-2-ene-4,9-dione (15a) : To a suspension of Ph 3 P(CH 2 OMe)Cl (436.4 mg, 1.27 mmol, 3.6 equiv) in THF (8.1 mL) was added KHMDS in toluene (2.1 mL, 1.06 mmol, 3.0 equiv) at 0°C, and the reaction mixture was stirred for 1 h. Then, the ylide solution (5.2 mL, ca. 0.15 mmol, ca. 1.5 equiv) was added to a stirred solution of 15 (122.0 mg, 0.354 mmol) in THF (3.5 mL), and the reaction mixture was stirred at 0°C. After the starting material disappeared, the reaction was quenched with saturated aqueous NH 4 Cl solution (20 mL). The aqueous layer was extracted with Et 2 O (20 mL×3). The combined organic layers were washed with brine (40 mL×1), dried (Na 2 SO 4 ), filtered, and evaporated. The crude 15a was used for the next step without further purification.
1-((1R*,5R*,7S*)-7-Allyl-2-methoxy-8,8-dimethyl-5-prenyl-4,9dioxobicyclo[3.3.1]non-2-ene)ethanal (15b):
To a stirred solution of 15a in a mixed solvent of acetone and H 2 O (acetone/H 2 O = 40/1, 3.5 mL) was added PTSA (134.7 mg, 0.708 mmol, 2.0 equiv) at room temperature. Then, the reaction mixture was warmed to 40°C. After the reaction was completed, saturated aqueous NaHCO 3 solution (20 mL) was added to the reaction mixture, and the aqueous layer was extracted with Et 2 O (10 mL×3). The combined organic layers were dried (Na 2 SO 4 ), filtered, and concentrated under reduced pressure. The crude aldehyde 15b was used for the next step without further purification.
(1R*,5R*,7S*)-1,7-Diallyl-2-methoxy-8,8-dimethyl-5-prenylbicyclo[3.3.1]non-2-ene-4,9-dione (14):
To a suspension of Ph 3 PMeBr (455.3 mg, 1.27 mmol, 3.6 equiv) in THF (10.6 mL) was added tert-BuOK (119.2 mg, 1.06 mmol, 3.0 equiv) at 0°C, and the reaction mixture was stirred for 1 h. Then, the ylide solution (4.0 mL, ca. 0.400 mmol, ca. 1.1 equiv) was added to a stirred solution of crude 15b in THF (3.5 mL) and the reaction mixture was stirred at 0°C. After the starting material disappeared, the reaction was quenched with saturated aqueous NH 4 Cl solution (10 mL). The aqueous layer was extracted with Et 2 O (10 mL×3). The combined organic layers were washed with brine (10 mL×1), dried (Na 2 SO 4 ), filtered, and evaporated. The residue was purified by flash chromatography (n-hexane-ethyl acetate, 15:1) to afford 14 (113.2 mg, 90%, (3 steps)) as an oil. Rf: 0.60 (n-hexane-ethyl acetate, 2:1). IR 
